Barings’s Integra LifeSciences IART Stock Holding History

Barings’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-11,000	Closed	-$609K	–	859
2018 Q1	$609K	Hold	11,000	–	–	0.01%	639
2017 Q4	$526K	Hold	11,000	–	–	0.01%	698
2017 Q3	$555K	Hold	11,000	–	–	0.01%	626
2017 Q2	$600K	Sell	11,000 -11,000	-50%	-$525K	0.02%	581
2017 Q1	$926K	Buy	22,000 +11,000	+100%	+$470K	0.01%	785
2016 Q4	$472K	Hold	11,000	–	–	0.01%	640
2016 Q3	$454K	Hold	11,000	–	–	0.01%	591
2016 Q2	$439K	Hold	11,000	–	–	0.01%	680
2016 Q1	$370K	Hold	11,000	–	–	0.01%	757
2015 Q4	$373K	Hold	11,000	–	–	0.01%	727
2015 Q3	$328K	Buy	+11,000	New	+$344K	0.01%	737
2014 Q1	–	Sell	-308,422	Closed	-$6.01M	–	935
2013 Q4	$6.01M	Sell	308,422 -518,931	-63%	-$9.52M	0.25%	85
2013 Q3	$13.6M	Buy	827,353 +313,293	+61%	+$5.03M	0.58%	32
2013 Q2	$7.7M	Buy	+514,060	New	+$7.53M	0.35%	60

Other funds holding IART

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Barings's IART Position: Q2 2018 in Review

Barings sold out of Integra LifeSciences (IART) in Q2 2018, closing a stake of 11,000 shares — an estimated $609K sold.

Barings first reported a position in IART in Q2 2013 and held it in 14 quarters. The position peaked at $13.6M in Q3 2013. 257 funds tracked by Wall St. Rank hold IART as of Q2 2018.

Barings reported no remaining Integra LifeSciences position as of Q2 2018 after selling out during the quarter.
Barings sold 11,000 Integra LifeSciences shares in Q2 2018, an estimated $609K.
Barings first reported a position in Integra LifeSciences in Q2 2013 and held it in 14 quarters.
Barings's Integra LifeSciences position peaked at $13.6M in Q3 2013.
257 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2018.

Based on Barings's 13F filing for Q2 2018, filed 3 Aug 2018.